Enhancing the physical stability and supersaturation generation of amorphous drug-polyelectrolyte nanoparticle complex via incorporation of crystallization inhibitor at the nanoparticle formation step: A case of HPMC versus PVP
2019 ◽
Vol 138
◽
pp. 105035
◽
2018 ◽
Vol 167
◽
pp. 483-491
◽
2013 ◽
Vol 4
(3)
◽
pp. 268-274
◽
Keyword(s):
2016 ◽
Vol 104
◽
pp. 156-163
◽
2015 ◽
Vol 76
◽
pp. 867-877
◽
2019 ◽
Vol 139
◽
pp. 500-508
◽
Keyword(s):
2015 ◽
Vol 104
(6)
◽
pp. 2076-2084
◽
2017 ◽
Vol 112
◽
pp. 196-203
◽
2018 ◽
Vol 537
◽
pp. 36-43
◽